Can SSRIs (including Lexapro) reduce the risk of long COVID? What the New Studies Show About SSRIs and Long COVID Over the past two years, long COVID has shifted from an emergency-era mystery to one of the most actively investigated chronic conditions in medicine. Among the more unexpected findings has been a series of large…

Emotional Dullness on Lexapro: What Did the Experiments Show? What the Escitalopram Experiment Found in Healthy Volunteers One of the clearest experimental demonstrations of “emotional dullness” on SSRIs comes from a recent study in which healthy volunteers, not patients with depression, were given 20 mg of escitalopram (Lexapro) or placebo daily for three weeks. This…

Meloxicam Price: Generic Options, Dosing Pearls, and the Pain–Mood Link Answer in a nutshell: Generic meloxicam is usually inexpensive; use the lowest effective dose and screen for GI/renal risk. Combine medication with function-focused strategies. Medically reviewed by John Smith, Jane Doe, Sarah Wilson Introduction Meloxicam is one of the most widely prescribed nonsteroidal anti-inflammatory drugs…

Can You Become “Immune” to Viagra? Tolerance Myths, Expectations, and Performance Anxiety Medically reviewed by PChina Jin LI (李锦) Institute of toxicology, Academy of Military Medical Sciences, Beijing Answer in a nutshell: There is no true “immunity” to sildenafil; inconsistent response often reflects dosing/timing, comorbidities, or anxiety. Fix mechanics and address performance anxiety. Introduction If…

Experimental Drug PA 915 Delivers Rapid, Lasting Antidepressant Effects in Stressed Mice A single dose of the experimental drug PA 915 rapidly eased depression- and anxiety-like behaviors in stressed mice. The benefits lasted up to eight weeks, suggesting a potential new path for rapid-acting antidepressants. Key Points A single dose of PA 915 produced fast-onset,…

Early Menopause Linked to Hidden Depression Crisis Women who experience premature menopause, when the ovaries stop working before age 40, face not only physical symptoms but also a heavy emotional toll. A new study finds that nearly one in three of these women suffer from depression, and the root causes appear to be more about…

Gut Microbes on the Mind: New Insight Links Gut Microbiota to Relief of Depression and Anxiety Emerging research suggests that specific gut microbiota may influence mood symptoms, offering fresh hope for new treatments for depression and anxiety, especially with probiotics interventions on the horizon. The findings highlight the potential of the gut–brain axis to shape…

“Depression Up 60% in a Decade” – 2025 CDC Report Finds Soaring Prevalence and 1 in 10 Adults on Antidepressants A new CDC analysis of national survey data finds that depression rates among U.S. adults have surged by nearly 60% in the past ten years. The report highlights widening demographic gaps, increasing reliance on antidepressants,…

Psychedelics 2.0: After MDMA’s Setback, Where Does the Field Go – and What About Psilocybin? Medically reviewed by PChina Jin LI (李锦) Institute of toxicology , Academy of Military Medical Sciences, Beijing Introduction The last decade has witnessed a rapid resurgence of interest in psychedelic-assisted therapies for psychiatric disorders. Driven by limited progress with conventional…

Accelerated Neuromodulation: SAINT and Other Fast-Track TMS Protocols Biao Wang, Keqing Li Medically reviewed by Paul E. Bebbington, MA, MPhil, FRCPsych; Phern-Chern Tor, MBBS; and Pichet Udomratn, MD | Last updated: 10.08.2025 Introduction For over two decades, transcranial magnetic stimulation (TMS) has offered hope to patients with treatment-resistant depression (TRD). Its noninvasive nature, favorable safety profile, and…